Top 20 Advanced Wound Care Companies 2020

Top 20 Advanced Wound Care Companies 2020

The global advanced wound care market was valued at $9.2bn in 2018. The largest segment of the advanced wound care market will continue to be active wound care throughout the forecast period. However, this segment will continue to lose market shares to wound care devices and wound care biologics sectors, from 55.2% in 2019 to 38.9% in 2029.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 129-page report you will receive 121 charts– all unavailable elsewhere.

The 129-page report provides clear detailed insight into the leading 20 companies in the advanced wound care market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

  • Global Advanced Wound Care Market forecast from 2019-2029
  • Forecast of the Global Advanced Wound Care Market by region:
  • North America
  • South America
  • Europe
  • Asia-Pacific
  • RoW
  • Our study discusses the selected leading companies that are the major players in the global advanced wound care market:
  • 3M Company
  • Acelity L.P. Inc.
  • B. Braun Melsungen AG
  • BSN Medical GmbH
  • Cardinal Health, Inc.
  • Celularity, Inc.
  • Coloplast A/S
  • ConvaTec Group plc
  • Generex Biotechnology Corp.
  • Hill-Rom Holdings, Inc.
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Lohmann & Rauscher GmbH & Co. Kg
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mölnlycke Health Care
  • Organogenesis
  • PAUL HARTMANN AG
  • Smith & Nephew
  • This report provides a SWOT analysis of the advanced wound care market.
  • This report also discusses factors that drive and restrain the market, as well as opportunities in the advanced wound care market.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1 Overview of the Global Advanced Wound Care Market
1.3 Benefits of This Report
1.4 Report Structure
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to the Advanced Wound Care Market
2.1 Advanced Wound Care Market Definition
2.1.1 Definition of Wound
2.1.2 Types of Wound
2.2 Advanced Wound Care Market Segmentation
2.2.1 Advanced Wound Care Market by Therapy
2.2.1.1 Traditional wound care
2.2.1.2 Advanced Wound Care
2.2.2 Advanced Wound Care Market by Biologics
2.2.2.1 Skin Replacement Therapies
2.2.2.2 Collagen-Based Therapies
2.2.2.3 Cell-Based Therapies
2.2.3 Advanced Wound Care market by Devices
2.2.3.1 Negative Pressure Wound Therapy (NPWT)
2.2.3.2 Ultrasound for Wound Therapy
2.3 Demand for Advanced Wound Care in Regional Markets
2.3.1 Americas Advanced Wound Care Market Overview - 2018
2.3.2 Europe Advanced Wound Care Market Overview- 2018
2.3.3 Asia-Pacific Advanced Wound Care Market 2018
3. Global Advanced Wound Care Market, 2018
3.1 Global Advanced Wound Care Market 2018 Overview
3.2 The World Advanced Wound Care Market: Industry Trends, 2018-2029
3.3 Drivers and Challenges for the Global Advanced Wound Care Market
3.3.1 Drivers
3.3.1.1 Increase in Aging Population:
3.3.1.2 Lifestyle Factors
3.3.1.3 Growing Incidence of Diabetes, Ulcers and Chronic Wounds
3.3.1.4 Technological Advancements and Government Initiatives
3.3.2 Challenges
3.3.2.1 High Cost Procedures
3.3.2.2 Disparity in Reimbursements
3.3.2.3 Reluctance to Accept New Technologies
3.3.3 Opportunities
3.3.3.1 Significant Growth Opportunities in Asia-Pacific and Developing Countries
3.3.3.2 Healthy Growth in the Active Wound Care Market
4. Leading 20 Companies Positioning in the Advanced Wound Care Market
4.1 Leading 20 Companies Ranking in the Advanced Wound Care Market
4.2 Global Advanced Wound Care Market Forecast, 2018-2029
5. Top 20 Advanced Wound Care Companies
5.1 Smith & Nephew Plc. Overview
5.1.1 Smith & Nephew Plc. Financial Outlook
5.1.2 Smith & Nephew Plc Product Portfolio
5.1.3 Smith & Nephew Plc Strategic Developments
5.2 Acelity (KCI and Systagenix) Overview
5.2.1 Acelity L.P. Inc. Financial Outlook
5.2.2 Acelity L.P. Inc. Product Portfolio
5.2.3 Acelity L.P. Inc. Strategic Developments
5.3 Mölnlycke Health Care AB Overview
5.3.1 Mölnlycke Financial Outlook
5.3.2 Mölnlycke Product Portfolio
5.3.3 Mölnlycke Strategic Developments
5.4 ConvaTec Group Plc Overview
5.4.1 ConvaTec Group Plc Financial Outlook
5.4.2 ConvaTec Group Plc Product Portfolio
5.4.3 ConvaTec Group Plc Strategic Developments
5.5 Coloplast A/S Overview
5.5.1 Coloplast A/S Financial Outlook
5.5.2 Coloplast A/S Product Portfolio
5.5.3 Coloplast A/S Strategic Developments
5.6 3M Company Overview
5.6. 3M Company Financial Outlook
5.6.2 3M Company Product Portfolio
5.6.3 3M Company Strategic Developments
5.7 B. Braun Melsungen AG Overview
5.7.1 B. Braun Melsungen AG Financial Outlook
5.7.2 B. Braun Melsungen AG Product Portfolio
5.7.3 B. Braun Melsungen AG Strategic Developments
5.8 BSN Medical GmbH Overview
5.8.1 BSN Medical GmbH Financial Outlook
5.8.2 BSN Medical GmbH Product Portfolio
5.8.3 BSN Medical GmbH Strategic Developments
5.9 Cardinal Health, Inc. Overview
5.9.1 Cardinal Health, Inc. Financial Outlook
5.9.2 Cardinal Health, Inc. Product Portfolio
5.9.3 Cardinal Health, Inc. Strategic Developments
5.10 Generex Biotechnology Corp. Overview
5.10.1 Generex Biotechnology Corp.Financial Outlook
5.10.2 Generex Biotechnology Corp. Product Portfolio
5.10.3 Generex Biotechnology Corp. Strategic Developments
5.11 Hill-Rom Holdings, Inc. Overview
5.11.1 Hill-Rom Holdings, Inc.Financial Outlook
5.9.2 Hill-Rom Holdings, Inc. Product Portfolio
5.11.3 Hill-Rom Holdings, Inc. Strategic Developments
5.12 Hollister, Inc. Overview
5.12.1 Hollister, Inc. Financial Outlook
5.12.2 Hollister, Inc. Product Portfolio
5.13 Integra LifeSciences Holdings Corporation Overview
5.13.1 Integra LifeSciences Holdings Corporation Financial Outlook
5.9.2 Integra LifeSciences Holdings Corporation Product Portfolio
5.13.3 Integra LifeSciences Holdings Corporation Strategic Developments
5.14 Lohmann & Rauscher GmbH & Co. Kg Overview
5.14.1 Lohmann & Rauscher GmbH & Co. Kg Financial Outlook
5.14.2 Lohmann & Rauscher GmbH & Co. Kg Product Portfolio
5.14.3 Lohmann & Rauscher GmbH & Co. Kg Strategic Developments
5.15 Medline Industries, Inc. Overview
5.15.1 Medline Industries, Inc. Financial Outlook
5.15.2 Medline Industries, Inc. Product Portfolio
5.16 Medtronic PLC Overview
5.16.1 Medtronic PLC Financial Outlook
5.16.2 Medtronic PLC Product Portfolio
5.16.3 Medtronic PLC Strategic Developments
5.17 Organogenesis Inc. Overview
5.17.1 Organogenesis Inc.Financial Outlook
5.17.2 Organogenesis Inc. Product Portfolio
5.17.3 Organogenesis Inc. Strategic Developments
5.18 PAUL HARTMANN AG Overview
5.18.1 PAUL HARTMANN AG Financial Outlook
5.18.2 PAUL HARTMANN AG Product Portfolio
5.19 Celularity, Inc.Overview
5.19.1 Celularity, Inc. Financial Outlook
5.19.2 Celularity, Inc. Product Portfolio
5.19.3 Celularity, Inc. Strategic Developments
5.20 Johnson & Johnson Overview
5.20.1 Johnson & Johnson Financial Outlook
5.5.2 Johnson & Johnson Product Portfolio
6 SWOT Analysis of the Global Advanced Wound Care Market
6.1 Strengths
6.2 Weaknesses
6.3 Opportunities
6.4 Threats
7. Conclusion
7.1 Continuous Innovation and a Strong R&D Pipeline
7.2 Higher Effectiveness Compared with Other Treatments
7.3 An Oligopolistic Market
7.4 Top 20 Companies and Revenue
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 2.1 The Global Advanced Wound Care Market Revenue Forecast ($bn), 2018-2029
Table 2.2 The North America Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
Table 2.3 The Europe Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
Table 2.4 Asia-pacific Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
Table 4.1 Companies Profiled in this Report and Country HQ
Table 4.2 Global Advanced Wound Care Market Revenue Forecast ($bn) and Annual Growth (%), 2018-2029
Table 5.1 Smith & Nephew Plc.: Key Facts, 2019
Table 5.2 Smith & Nephew Plc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.3 Smith & Nephew Plc.: Product Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.4 Smith & Nephew Plc.: Advanced Wound Management Revenue ($million), AGR (%) 2016-2018
Table 5.5 Smith & Nephew Plc.: Advanced Wound Management Product Revenue ($million) and Revenue Shares (%), 2018
Table 5.6 Smith & Nephew Plc.: Strategic Developments, 2015-2019
Table 5.7 Acelity L.P. Inc.: Key Facts, 2019
Table 5.8 Acelity L.P. Inc.: Strategic Developments, 2015-2019
Table 5.9 Mölnlycke: Key Facts, 2019
Table 5.10 Mölnlycke: Strategic Developments, 2015-2019
Table 5.11 ConvaTec Group Plc: Key Facts, 2019
Table 5.12 ConvaTec Group Plc: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.13 ConvaTec Group Plc: Advanced Wound Care Revenue ($million), AGR (%) 2016-2018
Table 5.14 ConvaTec Group Plc: Strategic Developments, 2015-2019
Table 5.15 Coloplast A/S: Key Facts, 2018
Table 5.16 Coloplast A/S: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.17 Coloplast A/S: Wound & Skin Care Revenue ($million), AGR (%) 2016-2018
Table 5.18 Coloplast A/S: Strategic Developments, 2015-2019
Table 5.19 3M Company: Key Facts, 2019
Table 5.20 3M Company: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.21 3M Company: Strategic Developments, 2015-2018
Table 5.22 B. Braun Melsungen AG: Key Facts, 2019
Table 5.23 B. Braun Melsungen AG: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2017
Table 5.24 B. Braun Melsungen AG: Outpatient Revenue ($million), AGR (%) 2015-2017
Table 5.25 B. Braun Melsungen AG: Strategic Developments, 2015-2018
Table 5.26 BSN Medical GmbH: Key Facts, 2018
Table 5.27 BSN Medical GmbH: Strategic Developments, 2015-2018
Table 5.28 Cardinal Health, Inc.: Key Facts, 2019
Table 5.29 Cardinal Health, Inc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.30 Cardinal Health, Inc.: Medical Segment Revenue ($million), AGR (%) 2016-2018
Table 5.31 Cardinal Health, Inc.: Strategic Developments, 2015-2019
Table 5.32 Generex Biotechnology Corp.: Key Facts, 2019
Table 5.33 Generex Biotechnology Corp.: Strategic Developments, 2015-2019
Table 5.34 Hill-Rom Holdings, Inc.: Key Facts, 2019
Table 5.35 Hill-Rom Holdings, Inc.: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.36 Hill-Rom Holdings, Inc.: Healthcare Revenue ($million), AGR (%) 2016-2018
Table 5.37 Hill-Rom Holdings, Inc.: Strategic Developments, 2015-2018
Table 5.38 Hollister, Inc.: Key Facts, 2018
Table 5.39 Integra LifeSciences Holdings Corporation: Key Facts, 2019
Table 5.40 Integra LifeSciences Holdings Corporation: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.41 Integra LifeSciences Holdings Corporation: Orthopedics & Tissue Technologies Revenue ($million), AGR (%) 2016-2018
Table 5.42 Integra LifeSciences Holdings Corporation: Strategic Developments, 2015-2018
Table 5.43 Lohmann & Rauscher GmbH & Co. Kg: Key Facts, 2018
Table 5.44 Lohmann & Rauscher GmbH & Co. Kg: Strategic Developments, 2015-2018
Table 5.45 Medline Industries, Inc.: Key Facts, 2018
Table 5.46 Medtronic PLC: Key Facts, 2018
Table 5.47 Medtronic PLC: Revenue ($million) and Revenue Shares (%) by Segment, 2018
Table 5.48 Medtronic PLC: Minimally Invasive Therapies Group Revenue ($million), AGR (%) 2016-2018
Table 5.49 Medtronic PLC: Minimally Invasive Product Revenue ($million) and Revenue Shares (%), 2018
Table 5.50 Medtronic PLC: Strategic Developments, 2015-2018
Table 5.51 Organogenesis Inc.: Key Facts, 2018
Table 5.52 Organogenesis Inc.: Strategic Developments, 2015-2018
Table 5.53 PAUL HARTMANN AG: Key Facts, 2019
Table 5.54 PAUL HARTMANN AG: Revenue ($million) and Revenue Shares (%) by Segment, 2018
Table 5.55 PAUL HARTMANN AG: Wound Management Revenue ($million), AGR (%) 2017-2018
Table 5.56 Celularity, Inc.: Key Facts, 2019
Table 5.57 Celularity, Inc.: Strategic Developments, 2015-2018
Table 5.58 Johnson & Johnson: Key Facts, 2019
Table 5.59 Johnson & Johnson: Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.60 Johnson & Johnson: Product Revenue ($million) and Revenue Shares (%) by Reporting Segment, 2018
Table 5.61 Johnson & Johnson: Wound Care/Other Revenue ($million), AGR (%) 2016-2018
Table 7.1 Top 20 Companies and Revenue, 2018 ($million)
List of Figures
Figure 4.1 Market share of key companies in advanced wound care market (%), 2018
Figure 4.2 Global Advanced Wound Care Market Revenue ($bn), 2018-2029
Figure 5.1 Smith & Nephew Plc.: Historical Revenues ($million, 2014-2018
Figure 5.2 Smith & Nephew Plc.: Revenue Shares (%) by Reporting Segment, 2018
Figure 5.3 Smith & Nephew Plc.: Revenue Shares (%) by Reporting Segment, 2018
Figure 5.4 Smith & Nephew Plc.: Revenue Shares (%) by Region, 2018
Figure 5.5 Smith & Nephew Plc: Advanced Wound Management Revenue ($million), 2016-2018
Figure 5.6 Smith & Nephew Plc.: Advanced Wound Management Product Revenue Shares (%), 2018
Figure 5.7 Mölnlycke : Historical Revenues ($million), 2014-2018
Figure 5.8 ConvaTec Group Plc: Historical Revenues ($million), 2014-2018
Figure 5.9 ConvaTec Group Plc: Revenue Shares (%) by Reporting Segment, 2018
Figure 5.10 ConvaTec Group Plc: Revenue Shares (%) by Region, 2018
Figure 5.11 ConvaTec Group Plc: Advanced Wound Care Revenue Shares (%), 2016-2018
Figure 5.12 Coloplast A/S: Historical Revenues ($million), 2014-2018
Figure 5.13 Coloplast A/S: Revenue Shares (%) by Reporting Segment, 2018
Figure 5.14 Coloplast A/S: Revenue Shares (%) by Region, 2018
Figure 5.15 Coloplast A/S: Wound & Skin Care Revenue ($million), 2016-2018
Figure 5.16 3M Company: Historical Revenues ($million), 2014-2018
Figure 5.17 3M Company: Revenue Shares (%) by Reporting Segment, 2018
Figure 5.18 3M Company: Revenue Shares (%) by Region, 2018
Figure 5.19 B. Braun Melsungen AG: Historical Revenues ($million), 2013-2017
Figure 5.20 B. Braun Melsungen AG: Revenue Shares (%) by Reporting Segment, 2017
Figure 5.21 B. Braun Melsungen AG: Revenue Shares (%) by Region, 2017
Figure 5.22 B. Braun Melsungen AG: Outpatient Revenue ($million), 2015-2017
Figure 5.23 Cardinal Health, Inc.: Historical Revenues ($million), 2014-2018
Figure 5.24 Cardinal Health, Inc.: Revenue Shares (%) by Reporting Segment, 2018
Figure 5.25 Cardinal Health, Inc.: Revenue Shares (%) by Region, 2018
Figure 5.26 Cardinal Health, Inc.: Medical Segment Revenue ($million), 2016-2018
Figure 5.27 Hill-Rom Holdings, Inc.: Historical Revenues ($million), 2014-2018
Figure 5.28 Hill-Rom Holdings, Inc.: Revenue Shares (%) by Reporting Segment, 2018
Figure 5.29 Hill-Rom Holdings, Inc.: Revenue Shares (%) by Region, 2018
Figure 5.30 Hill-Rom Holdings, Inc.: Healthcare Revenue ($million), 2016-2018
Figure 5.31 Integra LifeSciences Holdings Corporation: Historical Revenues ($million), 2014-2018
Figure 5.32 Integra LifeSciences Holdings Corporation: Revenue Shares (%) by Reporting Segment, 2018
Figure 5.33 Integra LifeSciences Holdings Corporation: Revenue Shares (%) by Region, 2018
Figure 5.34 Integra LifeSciences Holdings Corporation: Orthopedics & Tissue Technologies Revenue ($million), 2016-2018
Figure 5.35 Medtronic PLC: Historical Revenues ($million), 2014-2018
Figure 5.36 Medtronic PLC: Revenue Shares (%) by Segment, 2018
Figure 5.37 Medtronic PLC: Revenue Shares (%) by Product Type, 2018
Figure 5.38 Medtronic PLC: Revenue Shares (%) by Region, 2017
Figure 5.39 Medtronic PLC: Minimally Invasive Therapies Group Revenue ($million), 2016-2018
Figure 5.40 Medtronic PLC: Minimally Invasive Product Revenue Shares (%), 2018
Figure 5.42 PAUL HARTMANN AG: Revenue Shares (%) by Product Type, 2018
Figure 5.43 PAUL HARTMANN AG: Revenue Shares (%) by Region, 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook